Characterization of immunoglobulin heavy and light chain gene expression in chronic lymphocytic leukemia and related disorders

Cancer Science

Volumn 100, Issue 4, 2009, Pages 671-677

  Nakahashi, Hirotaka ^a   Tsukamoto, Norifumi ^a   Hashimoto, Yoko ^a   Koiso, Hiromi ^a   Yokohama, Akihiko ^a   Saitoh, Takayuki ^a   Uchiumi, Hideki ^a   Handa, Hiroshi ^a   Murakami, Hirokazu ^a   Nojima, Yoshihisa ^a   Karasawa, Masamitsu ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; CCND1 PROTEIN, HUMAN; CD19 ANTIGEN; CD5 ANTIGEN; CYCLIN D1; IMMUNOGLOBULIN E RECEPTOR;

ADULT; AGED; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; COHORT ANALYSIS; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; FOLLICULAR LYMPHOMA; GENE EXPRESSION PROFILING; GENE LOCATION; GENETIC DIFFERENCE; HAIRY CELL LEUKEMIA; HUMAN; HUMAN TISSUE; JAPANESE; LYMPHOMA; LYMPHOPLASMACYTIC LYMPHOMA; MAJOR CLINICAL STUDY; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA; SEQUENCE HOMOLOGY; SPLENIC MARGINAL ZONE LYMPHOMA; TISSUE DISTRIBUTION; GENETICS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGY; JAPAN; LYMPHOPROLIFERATIVE DISEASE; METABOLISM; MIDDLE AGED; MUTATION; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD19; ANTIGENS, CD5; COHORT STUDIES; CYCLIN D1; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULIN VARIABLE REGION; JAPAN; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOPROLIFERATIVE DISORDERS; MIDDLE AGED; MUTATION; RECEPTORS, IGE;

EID: 67449086643     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01092.x     Document Type: Article

References (41)

1. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumors. Tumors of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001.
2. Nishiyama H, Mokuno J, Inoue T. Relative frequency and mortality rate of various types of leukemia in Japan. Gann. 1969; 60: 71-81.
3. Weiss NS. Geographical variation in the incidence of the leukemias and lymphomas. Natl Cancer Inst Monogr. 1979; 53: 139-42.
4. Tamura K, Sawada H, Izumi Y et al. Chronic lymphocytic leukemia (CLL) is rare, but the proportion of T-CLL is high in Japan. Eur J Haematol. 2001; 67: 152-7.
5. Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 2006; 107: 265-76.
6. Damle RN, Wasil T, Fais F et al. IgV gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999; 94: 1840-7.
7. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated IgV(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999; 94: 1848-54.
8. Fais F, Ghiotto F, Hashimoto S et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest. 1998; 102: 1515-25.
9. Chiorazzi N, Ferrarini M. B cell chronic lymphocytic leukemia: Lessons learned from studies of the B cell antigen receptor. Annu Rev Immunol. 2003; 21: 841-94.
10. Johnson TA, Rassenti LZ, Kipps TJ. Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. J Immunol. 1997; 158: 235-46.
11. Schroeder HW Jr, Dighiero G. The pathogenesis of chronic lymphocytic leukemia: Analysis of the antibody repertoire. Immunol Today. 1994; 15: 288-94.
12. Tobin G, Thunberg U, Johnson A et al. Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: Implicating recognition of a common antigen epitope. Blood. 2003; 101: 4952-7.
13. Widhopf GF, Rassenti LZ 2nd, Toy TL, Gribben JG, Wierda WG, Kipps TJ. Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood. 2004; 104: 2499-504.
14. Murray F, Darzentas N, Hadzidimitriou A et al. Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: Implications for the role of antigen selection in leukemogenesis. Blood. 2008; 111: 1524-33.
15. Ghiotto F. Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J Clin Invest. 2004; 113: 1008-16.
16. Stamatopoulos K, Belessi C, Moreno C et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. Blood. 2007; 109: 259-70.
17. Messmer BT, Albesiano E, Efremov DG et al. Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med. 2004; 200: 519-25.
18. Koiso H, Yamane A, Mitsui T et al. Distinctive immunoglobulin VH gene usage in Japanese patients with chronic lymphocytic leukemia. Leuk Res. 2006; 30: 272-6.
19. Kipps TJ, Tomhave E, Pratt LF, Duffy S, Chen PP, Carson DA. Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 1989; 86: 5913-17.
20. Stamatopoulos K, Belessi C, Hadzidimitriou A et al. Immunoglobulin light chain repertoire in chronic lymphocytic leukemia. Blood. 2005; 106: 3575-83.
21. Ghiotto F, Fais F, Albesiano E et al. Similarities and differences between the light and heavy chain Ig variable region gene repertoires in chronic lymphocytic leukemia. Mol Med. 2006; 12: 300-8.
22. Abusedra A, Joshi R, Bybee A, Apperley JF, Wagner SD. V lambda genes in chronic lymphocytic leukemia: Highly skewed V gene segment usage with similar CDR3 sequences. Leukemia. 2008; 22: 1073-5.
23. Widhopf GF, Goldberg CJ 2nd, Toy TL et al. Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3. Blood. 2008; 111: 3137-44.
24. Isoda A, Yokohama A, Matsushima T, Tsukamoto N, Nojima Y, Karasawa M. The naive T-lymphocyte compartment is well preserved in patients with chronic myelogenous leukaemia in chronic phase. Br J Haematol. 2002; 119: 949-55.
25. Küppers R, Willenbrock K, Rajewsky K, Hansmann ML. Detection of clonal B-cell populations in paraffin-embedded tissues by polymerase chain reaction. Am J Pathol. 1993; 44: 230-9.
26. van Dongen JJ, Langerak AW, Brüggemann M et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 concerted action BMH4-CT98-3936. Leukemia. 2003; 17: 2257-317.
27. Marti GE, Rawstron AC, Ghia P et al. The international familial CLL consortium. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol. 2005; 130: 325-32.
28. Koiso H, Tsukamoto N, Miyawaki S, Shinonome S, Nojima Y, Karasawa M. Quantitative analysis of Cyclin D1 and CD23 expression in mantle cell lymphoma and B-chronic lymphocytic leukemia. Leuk Res. 2002; 26: 809-15.
29. Ghia P, Stamatopoulos K, Belessi C et al. ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia. Leukemia. 2007; 21: 1-3.
30. Ikematsu W, Ikematsu H, Okamura S, Otsuka T, Harada M, Niho Y. Surface phenotype and Ig heavy-chain gene usage in chronic B-cell leukemias: expression of myelomonocytic surface markers in CD5-chronic B-cell leukemia. Blood. 1994; 83: 2602-10.
31. Nakamura N, Kuze T, Hashimoto Y et al. Analysis of the immunoglobulin heavy chain gene variable region of 101 cases with peripheral B cell neoplasms and B cell chronic lymphocytic leukemia in the Japanese population. Pathol Int. 1999; 49: 595-600.
32. Farsangi MH, Jeddi-Tehrani M, Sharifian RA et al. Analysis of the immunoglobulin heavy chain variable region gene expression in Iranian patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2007; 48: 109-16.
33. Chen L, Zhang Y, Zheng W et al. Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia. Leuk Res. 2008; 32: 1491-1498.
34. Pugh-Bernard AE, Silverman GJ, Cappione AJ et al. Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. J Clin Invest. 2001; 108: 1061-70.
35. Rettig MB, Vescio RA, Cao J et al. VH gene usage is multiple myeloma: complete absence of the VH4.21 (VH4-34) gene. Blood. 1996; 87: 2846-52.
36. Foster SJ, Brezinschek HP, Brezinschek RI, Lipsky PE. Molecular mechanisms and selective influences that shape the kappa gene repertoire of IgM+ B cells. J Clin Invest. 1997; 99: 1614-27.
37. Ignatovich O, Tomlinson IM, Jones PT, Winter G. The creation of diversity in the human immunoglobulin V (lambda) repertoire. J Mol Biol. 1997; 268: 69-77.
38. de Wildt RM, Hoet RM, van Venrooij WJ, Tomlinson IM, Winter G. Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire. J Mol Biol. 1999; 285: 895-901.
39. Matthews C, Catherwood MA, Morris TC, Alexander HD. V(H)348 and V(H)353, as well as V(H)321, gene rearrangements define unique subgroups in CLL and are associated with biased lambda light chain restriction, homologous LCDR3 sequences and poor prognosis. Leuk Res. 2007; 31: 231-4.
40. HervéM, Xu K, Ng YS et al. Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity. J Clin Invest. 2005; 115: 1636-43.
41. Ghia EM, Jain S, Widhopf GF 2nd et al. Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection. Blood. 2008; 111: 5101-8.